Navigation Links
Endo Pharmaceuticals Holdings Inc. Announces Proposed Private Offering of Senior Notes
Date:5/26/2011

CHADDS FORD, Pa., May 26, 2011 /PRNewswire/ -- Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP) today announced a private offering of $700 million aggregate principal amount of senior unsecured notes. The notes will be unsecured, unsubordinated obligations of the Company and will be guaranteed by certain of the Company's subsidiaries.  

Endo intends to use the net proceeds of this offering, together with cash on hand and borrowings under its new credit facility, to finance its acquisition of American Medical Systems Holdings, Inc. ("AMS"), refinance Endo's existing credit facility and existing AMS indebtedness and pay related fees and expenses.

The notes and the related subsidiary guarantees have not been registered under the Securities Act of 1933, as amended, or any applicable state securities laws, and will be offered only to qualified institutional buyers in reliance on Rule 144A, and outside the United States in compliance with Regulation S under the Securities Act. Unless so registered, the notes and the related subsidiary guarantees may not be offered or sold in the United States except pursuant to an exemption from the registration requirements of the Securities Act and applicable state securities laws. This press release will not constitute an offer to sell or a solicitation of an offer to buy any notes or any other securities of Endo.

Note:

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These forward-looking statements include the following: Endo's intention to offer $700 million in aggregate principal amount of notes and Endo's intention regarding the use of the net proceeds of the offering. These statements are subject to
'/>"/>

SOURCE Endo Pharmaceuticals Holdings Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Calif. , May 1, 2015  AcelRx Pharmaceuticals, Inc. ... on the development and commercialization of innovative therapies for ... that Timothy E. Morris , chief financial officer ... of the events are as follows: Mizuho ... 5 Location:  The Omni Berkshire Place, New ...
(Date:4/30/2015)... April 30, 2015 Omnicell, Inc. (NASDAQ: OMCL ... solutions to healthcare systems, today announced results for its ... results: Revenue for the first quarter of 2015 was ... first quarter of 2014, and down $5.3 million or ... First quarter 2015 net income as reported in accordance ...
(Date:4/30/2015)... , April 30, 2015   Regulus Therapeutics Inc ... the discovery and development of innovative medicines targeting microRNAs, ... highlights for the quarter ended March 31, 2015 on ... close. Regulus will host a conference ... 5:00 pm Eastern Daylight Time to discuss its first ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Participate at Upcoming Investor Conferences in May 2Omnicell Announces First Quarter 2015 Results 2Omnicell Announces First Quarter 2015 Results 3Omnicell Announces First Quarter 2015 Results 4Omnicell Announces First Quarter 2015 Results 5Omnicell Announces First Quarter 2015 Results 6Omnicell Announces First Quarter 2015 Results 7Omnicell Announces First Quarter 2015 Results 8Omnicell Announces First Quarter 2015 Results 9Omnicell Announces First Quarter 2015 Results 10Omnicell Announces First Quarter 2015 Results 11Omnicell Announces First Quarter 2015 Results 12Omnicell Announces First Quarter 2015 Results 13Omnicell Announces First Quarter 2015 Results 14Omnicell Announces First Quarter 2015 Results 15Omnicell Announces First Quarter 2015 Results 16Omnicell Announces First Quarter 2015 Results 17Omnicell Announces First Quarter 2015 Results 18Omnicell Announces First Quarter 2015 Results 19Omnicell Announces First Quarter 2015 Results 20Omnicell Announces First Quarter 2015 Results 21Omnicell Announces First Quarter 2015 Results 22Omnicell Announces First Quarter 2015 Results 23Omnicell Announces First Quarter 2015 Results 24Omnicell Announces First Quarter 2015 Results 25Omnicell Announces First Quarter 2015 Results 26Omnicell Announces First Quarter 2015 Results 27Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for First Quarter 2015 Financial Results Webcast and Conference Call 3
... Eli Lilly and Company (NYSE: LLY ) ... chairman, president, and chief executive officer about his meeting ... economic growth, job creation, American innovation and competiveness: ... biopharmaceutical industry and take part in this very important ...
... NEW BRUNSWICK, N.J., Dec. 15, 2010 Johnson & ... Alex Gorsky, currently Worldwide Chairman, Medical Devices & Diagnostics ... been appointed Vice Chairmen of the Executive Committee and ... Chief Executive Officer, in an expanded Office of the ...
Cached Medicine Technology:Lilly Statement Regarding President Obama's Meeting With U.S. Business Leaders 2Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee 2Johnson & Johnson Announces Executive Appointments: Alex Gorsky, Vice Chairman, Executive Committee Sheri McCoy, Vice Chairman, Executive Committee 3
(Date:5/1/2015)... Turks and Caicos Islands, BWI (PRWEB) May 02, 2015 ... a new website! It is http://www.thevenetiangracebay.com , ... itself, and it incorporates the stunning white and attractive ... to a study of Google, sixty seven percent of ... The study showed that smartphones were used in ...
(Date:5/1/2015)... (PRWEB) May 01, 2015 Jusuru International ... for the successful repositioning of its flagship nutritional supplement, ... brand with a new name, new logo, new packaging, ... Ethos Awards are designed to identify and promote programs ... best. , “DSA congratulates Jusuru International for their ...
(Date:5/1/2015)... 2015 The Workgroup for Electronic ... on the use of health IT to create efficiencies ... resource to the United States Government Accountability Office (GAO) ... cards in Medicare. The report, “ Potential Uses of ... released to the public on Apr. 24, 2015 and ...
(Date:5/1/2015)... It’s raining bills on Capitol Hill with members in both ... for telemedicine. , “Such action is unprecedented in ... said Jonathan Linkous, CEO of the American Telemedicine Association (ATA). ... embrace the use of telecommunications in the delivery of care. ... to improve quality, access, equity and affordability of healthcare.”, ...
(Date:5/1/2015)... KY (PRWEB) May 01, 2015 Ernst ... CEO, Dr. Joshua Rosenthal, Co-Founder & CSO, and Burak ... finalists for the EY Entrepreneur Of The Year® ... Ernst & Young is a global leader in ... to be one of the top audit companies ...
Breaking Medicine News(10 mins):Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:ATA: Congress Floods the Halls with Telemedicine Proposals 2Health News:RowdMap, Inc. Named as a Ernst & Young Entrepreneur Of The Year® 2015 Award Finalist 2
... This release is available in Spanish . ... the same area as the original tumour remains the strongest, ... patients who have been free of disease for a very ... seventh European Breast Cancer Conference (EBCC7). Dr Sven Mieog, ...
... Milan, Italy, 24 March 2010 - Despite the aches and ... a positive outlook, remembering the positive experiences from their past. ... of Elsevier,s Cortex ( http://www.elsevier.com/locate/cortex ), reveals that ... lens is linked to the way in which the brain ...
... ... normal guides on how to assemble a hookah, a free video series demonstrating the ... ... go-to for information, TheHookahMonster.com’s marketing director, Mario Ferazzano, has decided to offer a free ...
... is best way to prevent breast cancer deaths , WEDNESDAY, ... does not appear to increase overall survival from the disease, ... instead be due to controlling risk factors and improved treatments, ... as we hoped years ago," said study author Dr. Karsten ...
... A ... Provo, ... 90 program--a new 90 day risk-free offer in the United States to try Tahitian Noni ... the appropriate amount of product for 90 days, then they can get their full purchase price ...
... ... Turn Back the Clock with a Proven, Personalized, Anti-Aging Program". Dr. Karlis Ullis shares how ... www.AskAnAntiAgingExpert.com . , ... March 24, 2010 -- What do the Today show, Hard Copy, Dateline NBC, and Sally ...
Cached Medicine News:Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 2Health News:Recurrence of breast cancer after more than 10 years is an important indicator of survival 3Health News:Older adults remember the good times 2Health News:TheHookahMonster.com Offers Free Shisha Tobacco Education 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 2Health News:Mammograms May Not Boost Survival, Danish Study Suggests 3Health News:Noni For 90 Offer Made By Tahitian Noni International 2Health News:Free Anti-Aging Teleseminar Teaches People Key Lifestyle Changes To Maximize Longevity 2
Townsend is a endocervical stainless-steel curette with round tapered tip....
Available in 5, 8 and 12 mm bite, with and without teeth....
...
...
Medicine Products: